Personal and vaccination history as factors associated with SARS-CoV-2 infection
- PMID: 33966881
- PMCID: PMC7972666
- DOI: 10.1016/j.medcli.2021.02.011
Personal and vaccination history as factors associated with SARS-CoV-2 infection
Abstract
Background and objective: SARS-CoV-2 has been and is a major global Public Health challenge. Since the beginning of the pandemic, different comorbidities have been postulated and associated with spectra of increased severity and mortality. The objectives of this research are: 1) to analyse the factors associated with SARS-CoV-2 infection (COVID-19) in a health area in northern Spain; 2) to understand the possible role of influenza vaccination and pneumococcal vaccination in the development of COVID-19.
Materials and method: A test-negative case-control study was conducted. Variables related to personal and vaccination history were considered. Although the epidemiological definition of the case varied over time, the reference definition was that corresponding to 31/01/2020 in Spain. A bivariate and multivariate analysis was performed.
Results: The sample included 188 patients, of which 63 were cases and 125 controls. The results show that obesity increases the risk 2.4-fold of suffering this infection (IC 95% 1,301-4,521) and ARA-2 increases it 2.2-fold (95% CI 1,256-6,982). On the other hand, anti-pneumococcal vaccination of 13 serotypes showed results close to statistical significance (OR = 0.4; 95% CI 0.170-1,006).
Conclusion: Obesity and the use of ARA-2 increases the risk of COVID-19. Scientific knowledge about factors associated with COVID-19 should be expanded. The authors consider that the present research raises the need further investigate the role of vaccines in this infection and their possible heterologous properties.
Keywords: COVID-19; Factores de riesgo; Risk factors; SARS-CoV-2; Vaccination; Vaccine; Vacuna.
Copyright © 2021 Elsevier España, S.L.U. All rights reserved.
Figures
Similar articles
-
Personal and vaccination history as factors associated with SARS-CoV-2 infection.Med Clin (Engl Ed). 2021 Sep 10;157(5):226-233. doi: 10.1016/j.medcle.2021.02.007. Epub 2021 Aug 9. Med Clin (Engl Ed). 2021. PMID: 34395910 Free PMC article.
-
Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals.Front Immunol. 2023 Nov 2;14:1247129. doi: 10.3389/fimmu.2023.1247129. eCollection 2023. Front Immunol. 2023. PMID: 38022626 Free PMC article.
-
Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans.JAMA Netw Open. 2021 Oct 1;4(10):e2128391. doi: 10.1001/jamanetworkopen.2021.28391. JAMA Netw Open. 2021. PMID: 34613401 Free PMC article.
-
Beneficial effects of SARS-CoV-2 vaccination resulting from the COVID-19 pandemic with regard to the uptake of influenza virus, pneumococcal, and herpes zoster adult vaccination - a narrative literature review.Ann Agric Environ Med. 2023 Dec 22;30(4):587-594. doi: 10.26444/aaem/176747. Epub 2023 Dec 20. Ann Agric Environ Med. 2023. PMID: 38153058 Review.
-
The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes.Reprod Toxicol. 2022 Dec;114:33-43. doi: 10.1016/j.reprotox.2022.10.003. Epub 2022 Oct 22. Reprod Toxicol. 2022. PMID: 36283657 Free PMC article. Review.
Cited by
-
Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19: A systematic review and meta-analysis.J Med Virol. 2024 Jan;96(1):e29343. doi: 10.1002/jmv.29343. J Med Virol. 2024. PMID: 38163281 Free PMC article.
References
-
- Organización Mundial de la Salud Virus de la gripe aviar y otros virus de la gripe de origen zoonótico. 2018 https://www.who.int/es/news-room/fact-sheets/detail/influenza-(avian-and...
-
- Organización Mundial de la Salud Coronavirus causante del síndrome respiratorio de Oriente Medio (MERS-CoV) 2019 https://www.who.int/es/news-room/fact-sheets/detail/middle-east-respirat...
-
- Organización Mundial de la Salud Declaración sobre la segunda reunión del Comité de Emergencias del Reglamento Sanitario Internacional (2005) acerca del brote del nuevo coronavirus (2019-nCoV) 2020 https://www.who.int/es/news-room/detail/30-01-2020-statement-on-the-seco...
-
- Organización Mundial de la Salud Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. 2020 https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual....
-
- Centro de Coordinación de Alertas y Emergencias Sanitarias . Ministerio de Sanidad; Madrid: 2020. Manejo clínico del COVID-19: atención hospitalaria. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual....
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous